p53 and MDM2: Antagonists or Partners in Crime?

Cancer Cell

Volumn 15, Issue 3, 2009, Pages 161-162

  Eischen, Christine M ^a   Lozano, Guillermina ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; PROTEIN BAX; PROTEIN MDM2; PROTEIN MDMX; PROTEIN NOXA; PROTEIN P53; PUMA PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

APOPTOSIS; CELL CYCLE ARREST; ENZYME ACTIVITY; ENZYME REGULATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHORT SURVEY;

EID: 60649090420     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.02.004     Document Type: Short Survey

References (9)

1. Enge M., Bao W., Hedström E., Jackson S.P., Moumen A., and Selivanova G. Cancer Cell 15 (2009) 171-183 this issue
2. Issaeva N., Bozko P., Enge M., Protopopova M., Verhoef L.G., Masucci M., Pramanik A., and Selivanova G. Nat. Med. 10 (2004) 1321-1328
3. Iwakuma T., and Lozano G. Mol. Cancer Res. 1 (2003) 993-1000
4. Jin Y., Lee H., Zeng S.X., Dai M.S., and Lu H. EMBO J. 22 (2003) 6365-6377
5. Moumen A., Masterson P., O'Connor M.J., and Jackson S.P. Cell 123 (2005) 1065-1078
6. Terzian T., Suh Y.A., Iwakuma T., Post S.M., Neumann M., Lang G.A., Van Pelt C.S., and Lozano G. Genes Dev. 22 (2008) 1337-1344
7. Vazquez A., Bond E.E., Levine A.J., and Bond G.L. Nat. Rev. Drug Discov. 7 (2008) 979-987
8. Vousden K.H., and Lu X. Nat. Rev. Cancer 2 (2002) 594-604
9. Zhang Z., Wang H., Li M., Agrawal S., Chen X., and Zhang R. J. Biol. Chem. 279 (2004) 16000-16006